Inventor · disambiguated record
Kevin Roehle
Also filed as: ROEHLE KEVIN
11 granted patents·4 pending applications·19 citations·filing 2020–2023
88Inventor score
Technology areasA61K
Files withIMMATICS BIOTECHNOLOGIES GMBH15
Top patents by PatentIndex Score
15 records- 0198US11214608B2Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jan 4, 2022·6 cites·20 claims
- 0298US11078253B2Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Aug 3, 2021·5 cites·20 claims
- 0398US11053296B2Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jul 6, 2021·5 cites·20 claims
- 0497US11248035B1Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Feb 15, 2022·3 cites·20 claims
- 0587US2024076349A1Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 0687US2024034769A1Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 0787US2023312680A1Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 0887US2023365651A1Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 0981US12065477B2Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Aug 20, 2024·0 cites·20 claims
- 1081US11919940B2Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Mar 5, 2024·0 cites·20 claims
- 1181US11345737B1Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted May 31, 2022·0 cites·20 claims
- 1280US11858978B2Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jan 2, 2024·0 cites·20 claims
- 1379US11840562B2Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Dec 12, 2023·0 cites·20 claims
- 1472US10899820B2Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·0 cites·20 claims
- 1572US10781244B2Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Sep 22, 2020·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Kevin Roehle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →